Developer docs
API playgroundTry for free, no card

Search company profiles

Fenix Group International

Full company profile

uuid000a7fa

Namestring
Fenix Group International
Legal namestring
Fenix Group International, LLC
Websiteurl
fenix.group
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Fenix Group International, LLC is a privately held, Reading, Pennsylvania-based consulting and technology firm focused exclusively on the life sciences industry, founded in 2016 and operating globally with offices in Reading, Barcelona, Dublin, Unterägeri (Switzerland), and Shanghai. The company delivers therapeutic area thought leadership across CV/Metabolism, Endocrinology, Oncology, Neurology, Infectious Disease, and Rare Disease to pharmaceutical, biotech, and medical device clients, addressing three pain points it identifies in the market: information overload, rapidly obsolete market insight, and stakeholder misalignment across organizations.

FENIX's offering pairs traditional management consulting with a proprietary cloud-based platform and an in-house engineering capability called FENIX Labs. The core platform comprises syndicated services (real-time dashboards, contextual landscaping, knowledge management), the FENIXapp mobile application, the FENIX Feed, MAP for non-linear market exploration, BLASTS for push-delivered market intelligence, and Profiles. Layered on top, the Boundary Pushers product line introduces applied AI features including HeyFENIX (NLP-powered voice and natural language queries on structured data), SLICER (automated augmentation of ClinicalTrials.gov records defining relationships between trials, assets, and sponsors), and Generative AI News Summaries, plus custom technology builds for clients.

FENIX makes money through three revenue streams: project-based management consulting fees for therapeutic area engagements, annual enterprise subscriptions for syndicated platform access (pricing not publicly disclosed), and a transaction-based marketplace at marketplace.fenix.group selling individual market intelligence "blasts" for $599 each. The company is organically funded with no disclosed external investment, claims penetration of 10 of the top 30 global life science companies, and holds ISO 27001 certification, 2024 Great Place to Work certification, and the 2018 Pharma CI Innovation Award.

Short descriptiontext

Fenix Group International is a privately held life sciences consulting and technology firm delivering therapeutic area market intelligence across CV/Metabolism, Oncology, Neurology, and Rare Disease to pharmaceutical, biotech, and medical device clients via consulting engagements, a syndicated cloud platform, and a self-serve marketplace.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersReading, United States
HQ citystring
Reading
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences consulting, pharmaceutical market intelligence, competitive intelligence services, syndicated market research, clinical trial analytics
NAICS code5 codes
  • Management, Scientific, and Technical Consulting Services5416
  • Management Consulting Services54161
  • Other Management Consulting Services541618
  • Marketing Consulting Services541613
  • Software Publishers5132
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Life Sciences Consulting
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Management Consulting Services
TypeProfessional Services
Description

Traditional consulting engagements providing therapeutic area thought leadership, market insights, and decision support to life science companies. Revenue generated through project-based consulting fees.

fenix.group
2Syndicated Services
TypeSubscription Recurring
Description

Subscription-based market intelligence services delivered through proprietary cloud-based platform. Includes real-time updates, dashboards, contextual landscaping, and mobile app access.

fenix.group
3Individual Content Purchases
TypeSubscription Recurring
Description

Marketplace model selling individual market intelligence blasts at $599 per piece, targeting individual researchers and professionals.

fenix.group
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Individual Blast Purchase
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

$599 per market intelligence blast article on the FENIX Marketplace. Includes access to the content and FENIX Free updates.

marketplace.fenix.group
2Enterprise Syndicated Services
ModelSubscriptionBilling cadenceAnnual
Notes

Enterprise-level subscription for syndicated services including dashboards, real-time updates, contextual landscaping, and team access. Pricing not publicly disclosed.

fenix.group
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1FENIX Labs
Description

In-house contextualized software engineering capability providing custom technology solutions for the life sciences industry, including NLP, ML, dashboards, and knowledge management platforms

fenix.group
+4 more records
Core offering1 text field

Fenix Group International is a global consulting firm delivering management consulting, syndicated market intelligence, and proprietary technology solutions to life sciences companies. It provides therapeutic-area thought leadership across CV/Metabolism, Endocrinology, Oncology, Neurology, Infectious Disease, and Rare Disease through an in-house engineering capability (FENIX Labs) that builds custom dashboards, NLP/ML tools, and knowledge management platforms. Its Syndicated Services Platform, mobile app, and marketplace enable real-time contextualized market landscaping, competitive intelligence, and decision support for pharmaceutical, biotech, and medical device clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 10 out of top 30 life science companies use FENIX services
+4 more records
Product overview1 text field

Fenix Group International offers a cloud-based syndicated services platform with multiple delivery mechanisms designed for the life sciences industry. The core portfolio includes: (1) Consulting Services providing therapeutic area thought leadership; (2) Syndicated Services Platform as the proprietary cloud-based hub for market insights; (3) FENIXapp mobile application for iOS and Android delivering push notifications; (4) Marketplace for purchasing individual market insights; (5) FENIX Feed as a social media-like curated content feed; (6) Dashboard for customized market intelligence display; (7) MAP for interactive market landscape visualization; (8) Profiles for dynamic therapy area data; (9) BLASTS for email-delivered market news; (10) HeyFENIX NLP voice interface for querying data; (11) SLICER for automated clinical trial analysis; (12) Generative AI News Summaries for automated content; and (13) FENIX Labs as the in-house engineering capability enabling custom builds. The platform integrates push (BLASTS, FENIXapp) and pull (Marketplace, MAP, Dashboard) experiences with AI-powered features including NLP and generative AI capabilities.

Product and service6 records
1Consulting Services
CategoryManagement Consulting
Description

Management consulting engagements providing therapeutic area thought leadership, market landscaping, competitive intelligence, and decision support to pharmaceutical, biotech, and medical device companies, built on more than 30 years of collective consulting experience.

2Syndicated Services Platform
CategoryMarket Intelligence Platform
Description

Proprietary cloud-based subscription platform delivering best-in-class market landscaping, knowledge management, and decision support to life science companies with real-time updates, dashboards, and team synchronization across all devices.

3FENIX Labs
CategoryCustom Technology Development
Description

In-house, contextualized software engineering capability providing software engineering, program management, UX/UI design, DevOps, digital marketing, and data science services specifically contextualized to the life sciences industry, enabling custom technology builds.

4FENIXapp
CategoryMobile Application
Description

Mobile application for iOS and Android providing push notifications for market intelligence blasts, favorited content, and category filtering, enabling users to access syndicated services on the go.

5FENIX Marketplace
CategoryContent Marketplace
Description

Cloud-hosted digital marketplace where users can access, search, and purchase individual market intelligence blasts at $599 each, providing direct self-serve access to FENIX's syndicated content without enterprise contracts.

6Custom Technology Builds
CategoryCustom Technology Development
Description

Tailored technology solutions designed by FENIX Labs, including trained AI/machine learning, NLP tools, interactive dashboards, and knowledge management platforms customized to specific client needs and industry context.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Stripe is used as the payment processor for FENIX's marketplace transactions and subscription billing. All financial information is stored by Stripe, with users encouraged to review their privacy policy.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pharma market intelligence and consensus forecasting platform focused on drug sales, pipeline, and commercial outlook — competes with FENIX's syndicated CI subscriptions and pipeline tracking.

TypeDirect peer
Description

Specialist life sciences consulting and analytics firm combining strategic consulting with technology-enabled evidence and market intelligence solutions — closest direct peer to FENIX's hybrid consulting-plus-tech model.

TypeBroad incumbent
Description

Largest global life sciences data, analytics, and consulting provider. Operates massive proprietary clinical, claims, and commercial data assets that compete with FENIX's curated intelligence offering for pharma CI budget.

TypeDirect peer
Description

Pharma and life sciences intelligence provider covering drug pipeline, clinical trials, patents, and competitive intelligence — direct overlap with FENIX's syndicated CI and trial-data tooling (SLICER).

TypeDirect peer
Description

Pharma intelligence platform covering clinical trials, regulatory, and commercial intelligence. Competes head-on with FENIX's competitive intelligence, pipeline tracking, and market monitoring products.

6ZS Associates
TypeDirect peer
Description

Global consulting firm with a large life sciences practice spanning commercial strategy, real-world evidence, and analytics — comparable consulting-plus-data orientation serving many of the same top-30 pharma clients.

TypeDirect peer
Description

Consulting firm with a dedicated Life Sciences practice providing economic, strategic, and commercial advisory to pharma and biotech — direct overlap in therapeutic-area commercial consulting.

TypeEmerging player
Description

Healthcare commercial intelligence provider with data on providers, payers, and biopharma customers — adjacent competitor to FENIX's market intelligence and account-level insights for life sciences clients.

TypeDirect peer
Description

Global data and analytics provider covering pharma, biotech, and healthcare markets with syndicated intelligence reports and databases that overlap FENIX's syndicated CV/met and broader TA products.

TypeBroad incumbent
Description

Global management consulting firm with a deep pharma practice — broader incumbent that competes for the same enterprise strategic consulting engagements FENIX wins with top-30 pharma clients.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI capability13 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fenix Group International

Life Sciences Consultingfenix.group

Fenix Group International is a privately held life sciences consulting and technology firm delivering therapeutic area market intelligence across CV/Metabolism, Oncology, Neurology, and Rare Disease to pharmaceutical, biotech, and medical device clients via consulting engagements, a syndicated cloud platform, and a self-serve marketplace.

What Fenix Group International does

Fenix Group International, LLC is a privately held, Reading, Pennsylvania-based consulting and technology firm focused exclusively on the life sciences industry, founded in 2016 and operating globally with offices in Reading, Barcelona, Dublin, Unterägeri (Switzerland), and Shanghai. The company delivers therapeutic area thought leadership across CV/Metabolism, Endocrinology, Oncology, Neurology, Infectious Disease, and Rare Disease to pharmaceutical, biotech, and medical device clients, addressing three pain points it identifies in the market: information overload, rapidly obsolete market insight, and stakeholder misalignment across organizations.

FENIX's offering pairs traditional management consulting with a proprietary cloud-based platform and an in-house engineering capability called FENIX Labs. The core platform comprises syndicated services (real-time dashboards, contextual landscaping, knowledge management), the FENIXapp mobile application, the FENIX Feed, MAP for non-linear market exploration, BLASTS for push-delivered market intelligence, and Profiles. Layered on top, the Boundary Pushers product line introduces applied AI features including HeyFENIX (NLP-powered voice and natural language queries on structured data), SLICER (automated augmentation of ClinicalTrials.gov records defining relationships between trials, assets, and sponsors), and Generative AI News Summaries, plus custom technology builds for clients.

FENIX makes money through three revenue streams: project-based management consulting fees for therapeutic area engagements, annual enterprise subscriptions for syndicated platform access (pricing not publicly disclosed), and a transaction-based marketplace at marketplace.fenix.group selling individual market intelligence "blasts" for $599 each. The company is organically funded with no disclosed external investment, claims penetration of 10 of the top 30 global life science companies, and holds ISO 27001 certification, 2024 Great Place to Work certification, and the 2018 Pharma CI Innovation Award.

Fenix Group International firmographics

Firmographics
Name
Fenix Group International
Legal name
Fenix Group International, LLC
Website
https://fenix.group
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
101–250 employees
Short description
Fenix Group International is a privately held life sciences consulting and technology firm delivering therapeutic area market intelligence across CV/Metabolism, Oncology, Neurology, and Rare Disease to pharmaceutical, biotech, and medical device clients via consulting engagements, a syndicated cloud platform, and a self-serve marketplace.
Ownership category
akta.pro rank

Where Fenix Group International is headquartered

Location

Headquarters

HQ city
Reading
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Fenix Group International business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Management Consulting Services: Traditional consulting engagements providing therapeutic area thought leadership, market insights, and decision support to life science companies. Revenue generated through project-based consulting fees.
  2. Syndicated Services: Subscription-based market intelligence services delivered through proprietary cloud-based platform. Includes real-time updates, dashboards, contextual landscaping, and mobile app access.
  3. Individual Content Purchases: Marketplace model selling individual market intelligence blasts at $599 per piece, targeting individual researchers and professionals.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goIndividual Blast Purchase
SubscriptionAnnualEnterprise Syndicated Services

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Fenix Group International product offering

Product offering

Core offering

Fenix Group International is a global consulting firm delivering management consulting, syndicated market intelligence, and proprietary technology solutions to life sciences companies. It provides therapeutic-area thought leadership across CV/Metabolism, Endocrinology, Oncology, Neurology, Infectious Disease, and Rare Disease through an in-house engineering capability (FENIX Labs) that builds custom dashboards, NLP/ML tools, and knowledge management platforms. Its Syndicated Services Platform, mobile app, and marketplace enable real-time contextualized market landscaping, competitive intelligence, and decision support for pharmaceutical, biotech, and medical device clients.

Product overview

Fenix Group International offers a cloud-based syndicated services platform with multiple delivery mechanisms designed for the life sciences industry. The core portfolio includes: (1) Consulting Services providing therapeutic area thought leadership; (2) Syndicated Services Platform as the proprietary cloud-based hub for market insights; (3) FENIXapp mobile application for iOS and Android delivering push notifications; (4) Marketplace for purchasing individual market insights; (5) FENIX Feed as a social media-like curated content feed; (6) Dashboard for customized market intelligence display; (7) MAP for interactive market landscape visualization; (8) Profiles for dynamic therapy area data; (9) BLASTS for email-delivered market news; (10) HeyFENIX NLP voice interface for querying data; (11) SLICER for automated clinical trial analysis; (12) Generative AI News Summaries for automated content; and (13) FENIX Labs as the in-house engineering capability enabling custom builds. The platform integrates push (BLASTS, FENIXapp) and pull (Marketplace, MAP, Dashboard) experiences with AI-powered features including NLP and generative AI capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • FENIX Labs: In-house contextualized software engineering capability providing custom technology solutions for the life sciences industry, including NLP, ML, dashboards, and knowledge management platforms
  • HeyFENIX
  • SLICER
  • FENIXapp
  • FENIX Feed

Products and services

  • Consulting Services Management consulting engagements providing therapeutic area thought leadership, market landscaping, competitive intelligence, and decision support to pharmaceutical, biotech, and medical device companies, built on more than 30 years of collective consulting experience.
  • Syndicated Services Platform Proprietary cloud-based subscription platform delivering best-in-class market landscaping, knowledge management, and decision support to life science companies with real-time updates, dashboards, and team synchronization across all devices.
  • FENIX Labs In-house, contextualized software engineering capability providing software engineering, program management, UX/UI design, DevOps, digital marketing, and data science services specifically contextualized to the life sciences industry, enabling custom technology builds.
  • FENIXapp Mobile application for iOS and Android providing push notifications for market intelligence blasts, favorited content, and category filtering, enabling users to access syndicated services on the go.
  • FENIX Marketplace Cloud-hosted digital marketplace where users can access, search, and purchase individual market intelligence blasts at $599 each, providing direct self-serve access to FENIX's syndicated content without enterprise contracts.
  • Custom Technology Builds Tailored technology solutions designed by FENIX Labs, including trained AI/machine learning, NLP tools, interactive dashboards, and knowledge management platforms customized to specific client needs and industry context.

Quantifiable outcome

  • 10 out of top 30 life science companies use FENIX services
  • +4 more outcomes

Companies that use Fenix Group International

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Fenix Group International technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability13 records

Feature6 records

Fenix Group International partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • StripecoreTechnology or IntegrationStripe is used as the payment processor for FENIX's marketplace transactions and subscription billing. All financial information is stored by Stripe, with users encouraged to review their privacy policy.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Fenix Group International competitors and assessment

Company assessment

Direct peers

  • Evaluate (formerly EvaluatePharma): Pharma market intelligence and consensus forecasting platform focused on drug sales, pipeline, and commercial outlook — competes with FENIX's syndicated CI subscriptions and pipeline tracking.
  • Trinity Life Sciences: Specialist life sciences consulting and analytics firm combining strategic consulting with technology-enabled evidence and market intelligence solutions — closest direct peer to FENIX's hybrid consulting-plus-tech model.
  • Clarivate: Pharma and life sciences intelligence provider covering drug pipeline, clinical trials, patents, and competitive intelligence — direct overlap with FENIX's syndicated CI and trial-data tooling (SLICER).
  • Citeline (Informa Pharma Intelligence): Pharma intelligence platform covering clinical trials, regulatory, and commercial intelligence. Competes head-on with FENIX's competitive intelligence, pipeline tracking, and market monitoring products.
  • ZS Associates: Global consulting firm with a large life sciences practice spanning commercial strategy, real-world evidence, and analytics — comparable consulting-plus-data orientation serving many of the same top-30 pharma clients.
  • Charles River Associates: Consulting firm with a dedicated Life Sciences practice providing economic, strategic, and commercial advisory to pharma and biotech — direct overlap in therapeutic-area commercial consulting.
  • GlobalData Healthcare: Global data and analytics provider covering pharma, biotech, and healthcare markets with syndicated intelligence reports and databases that overlap FENIX's syndicated CV/met and broader TA products.

Broad incumbents

  • IQVIA: Largest global life sciences data, analytics, and consulting provider. Operates massive proprietary clinical, claims, and commercial data assets that compete with FENIX's curated intelligence offering for pharma CI budget.
  • McKinsey & Company (Pharma & Medical Products practice): Global management consulting firm with a deep pharma practice — broader incumbent that competes for the same enterprise strategic consulting engagements FENIX wins with top-30 pharma clients.

Emerging players

  • Definitive Healthcare: Healthcare commercial intelligence provider with data on providers, payers, and biopharma customers — adjacent competitor to FENIX's market intelligence and account-level insights for life sciences clients.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Fenix Group International social profiles

Digital presence

Fenix Group International compliance and trust

Trust signal

Compliance1 record

Fenix Group International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fenix Group International leadership team

Management profile

Number of profiles

Profiles1 record

Fenix Group International subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Fenix Group International funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fenix Group International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fenix Group International

What does Fenix Group International do?

Fenix Group International is a global consulting firm delivering management consulting, syndicated market intelligence, and proprietary technology solutions to life sciences companies. It provides therapeutic-area thought leadership across CV/Metabolism, Endocrinology, Oncology, Neurology, Infectious Disease, and Rare Disease through an in-house engineering capability (FENIX Labs) that builds custom dashboards, NLP/ML tools, and knowledge management platforms. Its Syndicated Services Platform, mobile app, and marketplace enable real-time contextualized market landscaping, competitive intelligence, and decision support for pharmaceutical, biotech, and medical device clients.

Is Fenix Group International a public or private company?

Fenix Group International is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Fenix Group International founded?

Fenix Group International was founded in 2016. It employs 101 to 250 people.

Where is Fenix Group International based?

Fenix Group International is headquartered in Reading, United States, in the North America region.

How does Fenix Group International make money?

Three revenue lines are on record. Management Consulting Services are the primary driver. The others are syndicated Services and individual Content Purchases.

Who are Fenix Group International's main competitors?

Direct peers on record are Evaluate (formerly EvaluatePharma), Trinity Life Sciences, Clarivate, Citeline (Informa Pharma Intelligence), ZS Associates, Charles River Associates and GlobalData Healthcare. Broad incumbents are IQVIA and McKinsey & Company (Pharma & Medical Products practice). Definitive Healthcare is listed as an emerging player.

Does Fenix Group International have an API?

No public API is recorded for Fenix Group International.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales